Homeostasis during pregnancy and in the in utero environment is essential for prenatal development. Prenatal maturation is hallmarked by an orchestrated and rigorous developmental program characterized by critical cascades in multiple organ systems. During these critical periods of development, however, potential vulnerability to injury exists throughout pregnancy. Indeed, the developing central nervous system (CNS) is extremely vulnerable to environmental insults throughout the entirety of gestation. These insults can adversely affect the developing brain and spinal cord, and permanently alter the neurodevelopmental trajectory. Specifically, in utero insults and dysregulation of the maternal-placentalfetal axis can change molecular, cellular, structural, and functional development of the CNS, culminating in adverse outcomes and neurological disorders throughout postnatal life. In this review, we will discuss common infectious and toxin-induced in utero insults that have recently garnered attention, including Zika virus, prenatal opioid and alcohol exposure, and chorioamnionitis. The goals are to identify common pathophysiological mechanisms, to emphasize the urgent need for new diagnostic tools, and to promote a broader understanding of the diverse array of neurological outcomes presenting in these children throughout their lifespan. With an increasing number of infants exposed to in utero infections and toxins, and the expanding public health awareness of the consequences of Zika infection, the opioid crisis, alcohol consumption during pregnancy, and the frequency of preterm birth in the United States, familiarity with the underlying mechanisms of each of these insults is paramount to improve the diagnosis and treatment for this exceedingly vulnerable patient population. development with wide-ranging downstream consequences and lead to structural, functional, and multifaceted neurological deficits, and related comorbidities (1, 2).
Introduction
The development of the central nervous system (CNS) is a diverse and intricate process that begins early in gestation and continues into adulthood (Figure 1 ).
Commencing with extensive genesis and proliferation of neural cells in the first trimester of pregnancy, and progressing through maturation, migration and synaptogenesis in the second trimester, diverse neural networks are formed (1-3). Extending through the third trimester, the fetal brain develops gyri and undergoes extensive myelination and elaborate connectivity that continues to progress after birth. Indeed, dynamic models of neural development highlight the essential interplay of genetic, epigenetic and environmental factors in guiding, shaping and supporting the increasingly complex and elaborate architecture of the growing CNS (2-4).
Considering the highly orchestrated processes of CNS development, the fetal brain and spinal cord are exquisitely sensitive to alterations in the microenvironment during pregnancy, and disruptions in homeostasis can have molecular, cellular, structural and functional implications that are apparent throughout life. This precise and protracted development conveys an inherent and specific risk for the disorders that reflect the timing and the exact developmental processes interrupted by detrimental pathophysiology. Specifically, infections (viral or bacterial) and exposures to toxins (environmental or synthetic) during pregnancy can affect several aspects of prenatal CNS The placenta plays a key role in maintaining pregnancy, promoting and sustaining fetal growth, and protecting the fetus from foreign substances. It is also an important first line physical and immunological barrier against transmission of infectious and toxic agents during pregnancy (5). Recently, the placenta's unique role as a platform and interface for fetal maturity essential to CNS development has been appreciated in epidemiological, clinical and preclinical studies (6, 7). Detailed studies of placental injury can provide a forum for understanding the mechanisms common to fetal systemic inflammation, neuroinflammation and CNS injury (7) . Indeed, abnormalities in the placenta double the risk of neonatal encephalopathy (8-12). Minimizing CNS injury commencing in utero hinges on identification of critical pathways underlying the developmental program shared by both the placenta and CNS, such as inflammatory cell migration and recruitment, chemokine and growth factor signaling, and angiogenesis.
While disruptions in placental function directly affect maturation of all organ systems (13, 14) , the CNS is especially vulnerable, as its complexity and protracted development throughout gestation increases the propensity for injury at some point during pregnancy. Abnormal placental function and injury transmitted through the maternalplacental-fetal axis ( Figure 2 is detrimental to the developing CNS. Through comprehensive study of this axis, we can begin to dissect the mechanisms common to neurodevelopmental disorders, and identify innovative diagnostic tools and biomarkers of injury and repair. Further, we can develop novel, targeted, and age-appropriate therapeutic strategies, with the goal of stratifying infants to the care and treatment they need when they are born. Here, we will review current literature and focus on four etiologically unique insults that commence in utero and affect the maternal-placental-fetal axis in distinct ways. Individually, these insults represent examples of infection (Zika virus or bacterial chorioamnionitis) and toxins (alcohol and opioids), but each are sentinel injuries that affect the developing CNS.
Zika Virus
In 2016, the World Health Organization (WHO) declared Zika Virus (ZIKV) a Public Health Emergency of International Concern (PHEIC) based on an extraordinary cluster of neurological disorders and temporal association with ZIKV, with 1.3 million non-congenital cases and 2,160 congenital cases in 2015-2016 (15-18 (20) . Like malaria or yellow fever, ZIKV is a continuing regional threat rather than an urgent pandemic, however, the global risk assessment has not changed and ZIKV continues to spread geographically where competent vectors are present (20) . As of March 1, 2017, the national arboviral surveillance system (ArboNET) has reported 5,074 cases in the United States (US) and 38,306 cases in US territories (21).
The Aedes mosquito species are chiefly responsible for the transmission of ZIKV, a Flavivirus, to humans and are predominantly found in tropical and subtropical regions (22, 23), which explains the high prevalence of ZIKV in countries along the equator. Classified by two transmission cycles, sylvatic (jungle) and suburban-urban, ZIKV is transmitted to humans from other species, and between humans via multiple routes (24). The sylvatic cycle involves viral transmission via blood between nonhuman primates and mosquitos (25). Although this transmission cycle does not lead to direct infection in humans, it creates a large mosquito reservoir that heavily influences suburban-urban transmission. The suburban-urban cycle or human-mosquito-human transmission involves transmission of ZIKV from human to human, mosquito to human, or vice versa (25). The high rates of infection between humans is especially alarming because there are multiple routes of transmission and many infected adults are asymptomatic, which increases the risk of transmission prior to diagnosis (15, 25- In pregnant women who are suspected of ZIKV infection, ultrasonography is used to monitor potential microcephaly and other fetal and placental abnormalities, such as intrauterine growth restriction, anhydramnios and hydrops fetalis (5, 76-80). In the fetal brain, absence of corpus callosum, abnormal gyration, hydranencephaly, ventriculomegaly, brain atrophy, and/or cerebral calcifications can be found (18, 25, 28, 30, 41, 47, 51, 55, 65, 81, 82) . These neurodevelopmental anomalies can be detected as early as 18 to 20 weeks, but typically are not detected until the second and third trimester. A comprehensive review of the birth defects potentially related to ZIKV infection during pregnancy is presented in Honein et al., 2017 (49) .
The most profound symptom and hallmark of congenital ZIKV infection is microcephaly (16, 37, 47, 48, 51, 52, 55, (83) (84) (85) . Notably, the severe microcephaly that occurs with congenital ZIKV can often be accompanied by a fetal brain disruption sequence (FBDS), defined by overlapping cranial sutures, prominent occipital bone, craniofacial disproportion, and redundant scalp skin (54, 59, 86). In the US, microcephaly occurs in only a small subset of infected neonates, approximately 1-13% of all congenital ZIKV cases (55, 87, 88). The timing of viral exposure, viral load and gestational age of the fetus contributes to the severity of abnormalities in congenital ZIKV syndrome (16, 50, 59) . Infection during the first trimester of pregnancy is most likely to result in microcephaly and more severe neonatal outcome, because genesis and migration of neurons is occurring rapidly at that time (1-3, 5, 26, 55, 89) ( Figure  1 ). Concomitant with microcephaly, craniofacial disproportion and multiple abnormalities occur in major brain structures, such as the corpus callosum and cerebellum, predisposing the infant to multiple neurological impairments (55, 90-92). Postnatal infection of the neonate typically causes mild symptoms, similar to those observed in adults, and reflects the relative maturation of the CNS at term compared to early in gestation (65, 87, 88).
Clinically, microcephaly is defined as an abnormally small head size, which is measured using the occipitofrontal circumference (OFC). Microcephaly typically is diagnosed when the OFC at birth is less than the 3 rd percentile for age, when controlled for sex and gestational age (93). In severe cases of microcephaly, the skull may appear concave with overlapping sutures and abnormal skin folds (54, 86 (102) . ZIKV transmission can occur through the maternal-placental-fetal axis during pregnancy through the circulation (5). Placental macrophages and cytotrophoblasts are the cell types primarily responsible for transplacental transmission of ZIKV from the pregnant woman to the fetus (5, 45, [103] [104] [105] . Viral production in placental macrophages augments production of chemokines and cytokines, culminating in a robust inflammatory reaction (82, 89, 102, 106-108). In addition to placental cells, ZIKV also infects vascular epithelial cells (45, 103, 109) , resulting in cell death and disruption of major vessels in the placental barrier. Cumulatively, these changes create a toxic placental microenvironment defined by excessive hypoxia-ischemia and inflammation that subsequently facilitates CNS injury through limited oxygen and nutrient delivery, and inflammatory-driven neural cell death.
In addition to replicating in placental cells, ZIKV can overwhelm the maternal immune system and the placenta, and ultimately cross the immature blood-brain barrier to allow direct ZIKV uptake by neural cells (109) . Once ZIKV enters a cell, it hijacks essential replication and assembly machinery, interfering with proliferation and survival of neural progenitors (26). In contrast to the changes in the transcriptome induced by the Dengue virus, ZIKV has a robust and selective impact on genes involved in DNA replication and repair (35, 110) . Through specific cell-surface tyrosine kinase receptors such as AXL, and other adhesion molecules, ZIKV can invade developing radial glia, astrocytes, endothelia, microglia, and neural progenitor cells (35, 84, 111, 112) . Interestingly, AXL is also expressed on a subset of placental trophoblasts (55, 111, 112) and may correspond to the high efficiency of ZIKV infection in these cell types. Gene expression and proteomic analyses confirm several ZIKV-induced changes in protein and messenger RNA in infected neural cells, especially those 106, 109, 113, 114) . A neuroinflammatory reaction is also commonly observed, including microglial hyperplasia, astrocytic hypertrophy and macrophage, lymphocyte and leukocyte infiltration (94, 109, [115] [116] [117] . Indeed, this neuroinflammatory activation can drive neural cell pathophysiology through the release of chemokines and cytokines and further immune cell recruitment and activation (26). Similarly, preclinical models demonstrate replication of ZIKV in radial glia and neural progenitors, major hubs of neuronal migration and neurogenesis, and confirm substantial augmentation of apoptosis and autophagy mechanisms of cell death (35, 42, 43, 81, 89, 106, 114, 118, 119) . The cumulative impact of the changes that modify proliferation and migration dynamics is a dystrophic brain (109) . Overall, these data show CNS injury secondary to ZIKV-induced neural cell injury, plus ZIKV-induced placental insufficiency and inflammation, impairs neurogenesis and neural cell migration. The combination of placental and neural cell injury leads to microcephaly, encephalomalacia, hydrocephalus and additional CNS abnormalities common to congenital ZIKV syndrome (34, 78-80). Currently there is no cure for ZIKV; however, through increased understanding of ZIKV pathophysiology, preventative measures may be formulated and implemented, with treatments developed to aid the numerous infants born with brain injury secondary to congenital infection. Accordingly, current prevention efforts are focused on reducing infections in pregnant women by implementing travel restrictions prior to and during pregnancy, especially in geographical locations with known cases of Zika infection (25). Given the high probability of asymptomatic individuals (26), the CDC currently recommends high risk individuals, such as women who want to get pregnant or are pregnant, be screened and tested for Zika virus regularly (21). Like the CDC, the World Health Organization (WHO) also provides guidelines for preventing ZIKV transmission, and provides a framework for sexually active men and women in order to prevent possible adverse pregnancy and fetal outcomes (24). Specifically, in regions with active transmission of ZIKV, the WHO recommends pregnant women should consistently and correctly use condoms or abstain from sexual activity for at least the duration of the pregnancy (24). In regions with no active transmission of ZIKV, WHO recommends practicing safer sex or abstinence for a period of six months for men and women who are returning from areas of active transmission (24).
Prenatal Opioid Exposure
Opioid prescription rates have risen dramatically over the past several years, and according to the CDC, in some states, there are as many as 96-143 prescriptions for opioids per 100 adults per year (120). Similarly, there has been an increase in the number of overdose deaths involving heroin (121) , and 188,468 pediatric opioid exposures were reported to US poison control centers from 2000-2015 (122) . Consistent with this trend, substance use during pregnancy commonly occurs. Although concern regarding substance use in pregnancy is not new, it has recently increased with the breadth of the US opioid epidemic, including the impact on pregnant women and their infants (123, 124) . In 2011, the Substance Abuse Mental Health Services Administration
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Neurodevelopment Following Infectious and Toxic In Utero Insults 9 Copyright 2017 KEI Journals. All Rights Reserved. reported 1.1% of pregnant women abused opioids (125) , with opioid use in pregnancy increasing from 1.19 to 5.63 per 1000 births from 2000 to 2009 (126) . Commonly thought to be exclusively related to heroin, morphine, methadone and buprenorphine use, prenatal opioid exposure often also occurs through the use and abuse of prescription opioids such as oxycodone and codeine (123, 124, 127) . Indeed, several studies emphasize the increasing use of prescription opioids among women of childbearing age and pregnant women (123, 124, 128-130), with 22-30% of women filling at least one prescription for an opioid analgesic during pregnancy (129, 130) . A dramatic increase in opioid-substitution programs for the treatment of opioid addiction has also been observed (127, 131) .
Opioid receptors are located throughout the developing CNS, including in the cerebral cortex, amygdala, caudate, putamen and nucleus accumbens, and through their action on endogenous opioid receptors, act to relieve pain (132, 133). During pregnancy, however, opioids rapidly cross the placenta and via the fetal circulation have a direct impact on the developing fetal organ systems including the CNS (134) (135) (136) . For women with opioid use disorder, the abrupt discontinuation of opioids in pregnancy can result in preterm labor, fetal distress, or fetal demise (123, 127). Notably, the incidence of preterm birth among opioiddependent mothers is nearly 3 times the national average for non-opioid-dependent mothers (137, 138) , suggestive of placental inflammation and instability. Infants exposed to opioids in utero have increased neuropsychological dysfunction, including impaired executive function and attention (134, (139) (140) (141) (142) . While studies in adults indicate that opioids can induce structural CNS changes, with substantial changes in circuits related to pain and rewards, current knowledge of CNS changes in children with in utero opioid exposure is based on a few small studies (134, 143, 144) .
Clinical Presentation of Prenatal Opioid Exposure
As opioid use among pregnant women continues to rise, the rate of infants experiencing opioid withdrawal has similarly increased in the US. This postnatal syndrome, known as neonatal abstinence syndrome (NAS), is a withdrawal syndrome due to drug exposure in utero, and it has grown approximately five-fold in the past decade (123, 124). It is estimated that an infant suffering opioid withdrawal is born every 25 minutes (145, 146), and NAS occurs in 55-94% of newborns whose mothers were addicted to or treated with opioids while pregnant (127, 147) . In 2012, NAS was diagnosed in 21,732 infants in the US, and there is noted increased prevalence globally, including England, Canada and Western Australia (127, 148, 149) . However, 80% of opioid prescriptions worldwide are distributed in the US (122, 150) . NAS can result from the use of legitimately prescribed drugs, from the abuse of prescription drugs, or from the use of illegal opioids like heroin. Accordingly, maternal maintenance therapy, which includes treatment for opioid addiction with methadone or buprenorphine, can also result in withdrawal symptoms in the infant after delivery (151).
Owing to the timing of maternal drug use, drug type, and infant metabolism, the presentation of NAS may be delayed (123, 131, 147, 152, 153) . Similarly, diagnosis is often difficult due to relatively vague Medical Research Archives. Volume 5, issue 5. May 2017. (127) . While seizures and lethargy are readily apparent to clinicians, irritability, poor feeding and autonomic instability may have more subtle presentations. In term infants, the Finnegan Neonatal Abstinence Scoring System, also known as the modified Neonatal Abstinence Scoring System, may be used to quantify the severity of NAS and guide therapy (147, 154-156). The 21-item scale provides a cumulative score based on signs of neonatal opioid withdrawal (127, 147, 156, 157) . If the assessment reveals that a neonate has symptoms consistent with NAS, nonpharmacological interventions such as a calm rooming environment with minimal stimuli and supportive care are first implemented (125, 127, 158) . Pharmacologic intervention, such as morphine and methadone, are important components of clinical management when non-pharmacologic care is insufficient to mitigate signs and symptoms of NAS (127, 159) .
The Effects of Opioids on the Maternal-Placental-Fetal Axis
The pathophysiology of CNS injury related to prenatal opioid exposure is multifactorial and complex. The multifaceted social and environmental risk factors related to maternal health and prenatal care, in addition to the prenatal opioid exposure, also impact the developmental trajectory of the CNS (134) . Opioids readily cross the placenta through passive diffusion because they are typically water soluble and lipophilic, with low molecular weight (160) . Notably, as gestational age increases, transmission of opioids across the placenta also increases. This phenomenon is primarily related to the reduced developmental expression of Pglycoprotein (P-gp), a drug efflux transporter that has decreasing levels and activity with increasing gestational age (125, 161) . This facilitates an increased rate of opioid transfer from the maternal to the fetal circulation (125, 161) . Indeed, clinical consequences of maternal opioid use in the fetus can lead to notable intrauterine growth restriction, abruption placentae, and preterm labor (124, 127, 137, 161, 162) . Opioids affect placental integrity and function, leading to reduced nutrient and oxygen delivery to the fetus, consistent with stress and injury through the maternal-placental-fetal axis (136, 152) . Given the role of the placenta in the metabolism and transfer of opioids to the fetus, it is clear that placental function is also a critical determinant of fetal CNS injury and clinical presentation of opioidrelated symptoms following birth (127, 147, 163) .
Clinical outcomes in the newborns and children exposed to opioids in utero, including heroin, reveal low birth weight, small head circumference, and smaller brain volumes (124, 127, 134, 162, 164) . Specifically, these children have a smaller pallidum and putamen (164) . These deep nuclei are critical to the function of frontal-striatal circuits implicated in attention and locomotor activity (164) (165) (166) . Volumes of the basal ganglia, thalamus, and cerebellar white matter are also reduced in children with prenatal opioid exposure (134) . Beyond standard structural imaging, diffusion tensor imaging (DTI) studies reveal white matter microstructural abnormalities indicative of impaired connectivity and abnormal cerebral circuit development, including reduced fractional anisotropy and increased radial diffusion in deep, central and posterior white matter tracts in infants with opioid exposure (134) . Alteration of these white matter tracts place children at risk for cognitive and behavioral difficulties including lower mental developmental index, shorter attention spans, and poor social engagement throughout life (167) . These data are consistent with the hypothesis that prenatal opioid exposure has direct neurotoxic and gliotoxic effects (168) , and may be especially detrimental to developing neural cells prior to myelination of axons. Additionally, opioid receptors are present on neurons, oligodendroglia and astroglia (169) , and opioid receptor activation may directly affect neural cell migration and survival (164) . In preclinical studies, opioid exposure results in an increase of apoptosis in human neurons and microglia in vitro (168) , as well as reduced dendrite length and branching in cortical neurons concomitant with deficits in learning and memory in rodents (134, 170, 171) . Collectively, these data emphasize the detrimental effects of opioid exposure on CNS structure and function. Pregnant women and children are frequently overlooked in the efforts to prevent opioid exposures, and the incidence of NAS and associated increases in health care costs warrant a consistent and comprehensive approach to mitigating the negative outcomes for affected infants, their mothers, and the health care system (122, 127) .
Prenatal Alcohol Exposure
The global prevalence of alcohol use in pregnancy is estimated to be 9.8% (172, 173) . Like ZIKV and opioid use in pregnancy, prenatal alcohol exposure (PAE) is an expansive public health problem.
Despite current CDC recommendations to abstain from alcohol use before and during pregnancy (174) , approximately 10-15% of women in the US report drinking some alcohol during their pregnancy, with 3-5% confirming heavy drinking throughout all stages of pregnancy (175, 176) . The impact of PAE is devastating, and is the principle cause of fetal alcohol syndrome (FAS) (177) (178) (179) . FAS in the general population is estimated at 14.6 per 10,000 people, and it is projected that 1 in every 67 women who consume alcohol during pregnancy will deliver a child with FAS (172) . Indeed, FAS is a disabling potential outcome of drinking during pregnancy, and is the most severe and visibly identifiable form of fetal alcohol spectrum disorder (FASD) (172, (180) (181) (182) (183) . Representing a multitude of behavioral and cognitive disorders (174, 180, 184) , the American Academy of Pediatrics (AAP) estimates that 2-5% of first grade students suffer from a combination of deficits associated with FASD (174, 176) .
Alcohol use during pregnancy is an established risk factor for adverse antenatal outcomes including stillbirth, spontaneous abortion, preterm birth, intrauterine growth restriction and low birth weight (185) (186) (187) (188) . Together, these insults place infants at risk for microcephaly, epilepsy, cerebral palsy, cognitive deficits and attention deficit disorders (179, 181, (189) (190) (191) (192) including opioids (190) . PAE impairs hippocampal-mediated working memory, synaptic plasticity, cerebellar-motor coordination, cortical organization, executive functioning, motor function and social behavior, but also augments attention disorders and neuropsychiatric disorders, all of which become more apparent and debilitating throughout life (192) (193) (194) (195) (196) (197) (198) (199) (200) (201) .
Clinical Presentation of PAE
FASD causes a spectrum of clinical abnormalities in the developing infant, and commonly affects the CNS, ocular, craniofacial, cardiovascular and endocrine systems (For Review see Del Campo 2016) (202) . Infants born with FASD are commonly classified as small for gestational age (<10%tile for age), which is associated with poor neurodevelopmental outcomes compared to infants born with appropriate weight, length and OFC for gestational age (203) . Infants with FASD may present with facial dysmorphisms, hallmarked by short palpebral fissures, an elongated mid-face, long and flat philtrum, thin upper vermilion, flattened maxilla, and hypoplasia of the nasal bridge (For Review see Del Campo 2016) (202) . PAE interferes with highly sophisticated neurodevelopmental pathways during gestation, which can lead to multiple CNS abnormalities. Notably, development of the face and the brain are intimately connected, as the brain provides the structural, cellular, and molecular input that guides the development of the face (202) .
Using standard and advanced imaging techniques, structural and diffusion MRI investigations reveal significant brain injury in multiple regions, including the frontal cortex, corpus callosum, striatum, caudate nucleus, thalamus and cerebellum (191, 192, (194) (195) (196) (197) (198) (199) (200) . Significantly, the corpus callosum, a major white matter structure essential for interhemispheric communication, has been reported to be disproportionately smaller in alcoholexposed neonates (195, 199, 200, (204) (205) (206) . Structural deficits in the corpus callosum may lead to poor cognitive performance, and impaired sensory, motor and higher-order neural communication (204) (205) (206) , as a result of poor connectivity, dysregulated interhemispheric integration, and impaired processing. Likewise, diffusion imaging studies link abnormal callosal microstructure and structural coherence with impaired myelination, diffuse fiber bundles and poor axonal integrity (204, 207) . Significantly, these neuroimaging studies corroborate the first autopsy studies of FAS, including those revealing impaired cell migration, and agenesis or thinning of the corpus callosum (183, 208) .
Aggregate effects on neural cell proliferation, migration and connectivity yield a spectrum of PAE-related intellectual, behavioral and cognitive deficits, which become more pronounced during an affected individual's life. At the structural level, the first trimester effects of alcohol toxicity, like ZIKV, manifest as impaired neural tube development and microcephaly. The facial dysmorphology characteristics are often present and include other midline structures, such as the corpus callosum (202, 209) . Primarily, these sequelae are related to impaired cell migration, neurogenesis, synaptogenesis, and oligodendrogenesis (209) . In the second and third trimesters, alcohol perturbs cell proliferation and induces errors in migration, while directly activating the molecular machinery of cell death pathways, thereby catalyzing massive amounts of pathological cell death, impaired synaptic plasticity, and oxidative stress, thus resulting in longterm functional and behavioral deficits (209) .
Effects of Ethanol on the Maternal-Placental-Fetal Axis
Alcohol consumed by pregnant women easily diffuses through the maternalplacental-fetal axis, and places fetal CNS development at risk (189, 190, 210) . Specifically, placental dysfunction secondary to maternal alcohol consumption, plus augmented and prolonged alcohol exposure to the fetus, are highly damaging to the developing CNS. Alcohol impairs placental growth and increases perfusion pressure, which results in structural changes in the placenta, and reduced blood flow and nutrient transport to the fetus throughout pregnancy (190, 211, 212) . Together with the direct toxicity and teratogenic effects of alcohol, newborns exposed to alcohol in utero have a higher probability of poor neurological outcomes due to significant placental dysfunction, including insufficiency and inflammation (190) . Prior to 20 weeks' gestation, alcohol crosses the placenta into the amniotic fluid and directly diffuses into the fetus through the immature fetal dermis (189, 213) . After 20 weeks' gestation, the fetus begins absorbing alcohol that has passed into the amniotic fluid via swallowing and intramembranous absorption (189, 213) . Consistent with the normal cycling of amniotic fluid, alcohol is recycled such that alcohol is excreted unchanged in fetal urine, and again subject to reuptake (213, 214) . Compounding these mechanisms, umbilical vessels are extremely sensitive to alcohol and increased placental resistance (210) . This effect of alcohol on the umbilical cord vessels results in vasoconstriction and further impairment of alcohol elimination rates from the fetal compartment (211) . Women who drink alcohol during pregnancy also have a 5 to 7-fold increased risk of infection, such as chorioamnionitis (215) . The increased risk of chorioamnionitis leads to further increased incidence of preterm birth. Together, these effects compound the direct effect of alcohol toxicity on the developing CNS by facilitating hypoxiaischemia and decreasing oxygen availability to the developing fetus. While the severity of structural and functional CNS injury associated with fetal alcohol exposure is multifactorial, key cellular and molecular mechanisms contribute to the pathophysiology. Alcohol readily interacts with glutamate and γ-aminobutyric acid (GABA) receptors (GABA A R), where it acts as an antagonist and agonist, respectively (209, 216) . At GABA A Rs, alcohol is a positive allosteric modulator, facilitating GABAergic neurotransmission (216) . This receptor-mediated effect has profound impacts on excitatory and inhibitory neurotransmission. In adults, facilitation of GABAergic neurotransmission defines the CNS depression and disinhibition related to alcohol consumption (216) . However, given that GABAergic signaling is more prominent in the developing CNS, the resultant environment favors neuronal excitation and neurotoxicity related to developmental timing of potassium chloride co-transporters that direct chloride gradients in neural cells (217) (218) (219) (220) . Alcohol also modulates presynaptic glutamate release (209) , which further dysregulates synaptic signaling in the developing CNS (209) . Besides these effects on neurotransmitter receptors, alcohol increases free radical production,
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14 Copyright 2017 KEI Journals. All Rights Reserved. stresses cellular metabolism via increasing acetylaldehyde levels, directly facilitates cell death through mitochondrial injury, caspase activation and DNA fragmentation, and limits production of essential neurotrophic factors (209) . Taken together, it is clear that alcohol has multiple detrimental mechanisms of action that creates a cerebral microenvironment toxic to developing neural cells and favoring cell death.
Chorioamnionitis
Chorioamnionitis (CHORIO), defined as inflammation of the placenta and surrounding membranes and representing a combination of infection plus hypoxiaischemia (HI), has recently been appreciated in a significant number of preterm and term infants with perinatal brain injury, including those with stroke (145, 146, [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] . CHORIO is the most common abnormality found in placentas from very preterm infants, and is a principle cause of preterm birth (221, 223, 224, 232) . Preterm birth, or delivery prior to 37 weeks' gestation, is the primary cause of perinatal morbidity and mortality in developed countries and impacts approximately 12% of all deliveries in the US (233).
Preterm infants are at increased risk for numerous neurological complications including intraventricular hemorrhage, encephalopathy of prematurity, and periventricular leukomalacia (234) (235) (236) . Among children born at <28 weeks estimated gestational age (EGA), 30 to 50% will have borderline (IQ<85) or severe (IQ<70) cognitive delay (237) . Typically, deficits are cumulative and children with cognitive and behavioral problems often have cerebral palsy, impaired learning, vision and hearing loss, epilepsy, and overall poor physical health that contributes to the prematurity-related burden of chronic disease in adulthood (238, 239) . Owing to cognitive and behavioral impairments, children have more trouble coping with other deficits and experience difficulty transitioning to adult independence (240) . The resultant societal costs are extensive and exceed an estimated annual expense of 26 billion US dollars, an estimate that even then significantly underestimates the special education, neuropsychiatric and medical management required for former preterm infants as they age (241) . Indeed, recent recognition that prenatal care and prevention efforts are ineffective in reducing the burden associated with neonatal mortality and morbidity in the US collectively emphasizes the absolute necessity that novel neural repair strategies and pathophysiological mechanisms be identified (242, 243) .
Specifically, CHORIO affects 40-80% of very preterm deliveries, and 20-34% of deliveries at term (222, 244, 245) . In term infants with HI encephalopathy, the presence of CHORIO predicts limited responsiveness to hypothermia treatment (244, 246) . Indeed, recent neuroimaging studies of preterm infants with detailed placental histology and neonatal neuroimaging at term equivalent age show histological CHORIO is an independent antenatal risk factor for preterm brain injury (247) . Additionally, placental abnormalities are an independent risk factor in the pathogenesis of perinatal stroke (223, 224, (248) (249) (250) .
CHORIO is most often caused by infection
with Mycoplasma or Ureaplasma species (251, 252) . With progression through the maternalplacental interface and into the fetus, CHORIO induces fetal inflammatory (221, 253) . FIRS exacerbates the detrimental effects of CHORIO on long-term neonatal outcome, increasing the risk of neonatal sepsis, intraventricular hemorrhage, bronchopulmonary dysplasia and cerebral palsy through a massive fetal immune reaction with increased cytokine production and immune cell recruitment (221, (254) (255) (256) (257) (258) (259) (260) (261) . In the absence of other risk factors, the cytokine milieu of CHORIO can facilitate a hypercoaguable state or cause direct thromboembolism to the fetal brain (260, 262) . Notably, prenatal and postnatal inflammatory pathophysiology predicts severe neurologic sequelae later in life (10-12), with the risk for abnormal neurologic outcome highest for preterm infants with both CHORIO and placental perfusion defects (10-12).
Clinical Presentation of CHORIO
There are numerous risk factors for development of CHORIO including premature prolonged rupture of the membranes, long duration of labor, nulliparity, Group B Streptococcus (GBS) infection, urinary tract infections (252, 263), prenatal alcohol exposure, and prenatal opioid exposure (215) . CHORIO is diagnosed with clinical or histological criteria (222, 227, 252, 264) . Maternal fever (temperature greater than 100.4°F), maternal tachycardia (>100 beats per minute), fetal tachycardia (>160 beats per minute), uterine fundal tenderness, and purulence or foul odor of amniotic fluid are all symptoms of clinical CHORIO (252, 264). The histological diagnosis of CHORIO is made by placental and umbilical cord pathology. It is defined as inflammation of the chorion, amnion and placenta, and robust presence of polymorphonuclear leukocytes (PMNs), amnion basement membrane thickening and chorionic microabscesses (60, 146, 232, 265, 266) . Often, CHORIO co-occurs with decidual vasculopathy, villous infarction, and increased perivillous and intervillous fibrin deposition (267) . Significantly, CHORIO affects placental permeability and blood flow (267) , facilitating HI and transmission of inflammation to fetuses of all gestational ages (262) . With histological signs of CHORIO present in as many as 42% of placentas from unremarkable pregnancies (261, 262) , it is paramount that greater understanding of the role of sterile and non-sterile placental inflammation in pregnancy be ascertained.
Effects of CHORIO on the Maternal-Placental-Fetal Axis
The pathophysiology of CHORIO is hallmarked by inflammation and HI, at the maternal-placental interface that directly impacts the fetal microenvironment (259) . Uteroplacental hypoperfusion leads to fetal hypoxia and diminishes fetal nutrition, including impaired removal of metabolic products from circulation (146, 259, 265, (268) (269) (270) (271) (272) . CHORIO generates substantial inflammation and engenders a placental, fetal systemic, and fetal CNS inflammatory response characterized by a robust and highly dysregulated proinflammatory cytokine and chemokine profile (146, [273] [274] [275] . Cytokines are soluble immune mediators secreted in response to immunological challenges such as infection, and are essential for normal CNS development and normal labor and delivery (276) . The birth process is typically associated with a measured cytokine cascade initiated by inflammatory infiltration of the cervix, fetal membranes, and myometrium, which highlights the homeostatic and physiologic roles of cytokines in normal development (253, 277) . Despite this, aberrant cytokine production with infection that affects the maternal-fetal interface in the context of ascending infection from the lower genital tract to the chorioamnion is a major component of extreme preterm labor (232, 266, [278] [279] [280] [281] . Cytokines produced in response to intrauterine infection and inflammation cause damage to the developing CNS (273) (274) (275) . Notably, clinical data reveal that preterm newborns have extensive and extended elevations in inflammatory proteins throughout the perinatal period and elevations in multiple, distinct functional inflammatory protein classes (282) (283) (284) . Together, these features are strongly linked to neurologic impairment in these infants later in life (282) (283) (284) .
CHORIO triggers an inflammatory response in maternal-placental-fetal axis that can result in injury to the fetal brain and impair neurodevelopmental trajectory both before and after birth (285, 286) . Fetal inflammation initiates a neuroinflammatory response through peptides, cytokines, and bacterial products in circulation that cross the blood-brain barrier (285, 286) , followed by a controlled innate immune response activation by CNS cells such as microglia and peripheral immune cells including neutrophils and leukocytes. Microglia are the innate immune cells of the brain and their activation enables neuroinflammation and modulates excitotoxicity and free radical injury. Together with direct effects on developing brain circuitry and oligodendrocytes, the primary result is cell death and diffuse encephalopathy involving profound gray and white matter injury (287) (288) (289) (290) . Indeed, numerous studies confirm decreased microstructure in the corpus callosum, cingulum, internal capsule, external capsule and cerebellum. Together with changes in the thalamus in preterm infants, these abnormalities correlate with poor outcome later in life, especially with respect to cognitive, behavioral, and motor performance (221, 247, 258, (291) (292) (293) (294) (295) (296) . Like ZIKV, prenatal alcohol exposure, and neonatal abstinence syndrome, the brain injury associated with CHORIO and preterm birth is easily an expansive review topic in its own right, with numerous contributions from multidisciplinary investigative teams around the globe. However, most data overwhelmingly support that injury begins in utero for a significant proportion of preterm infants and emphasize the absolute necessity of methods for detecting fetuses and placentas at risk as a means of reducing brain injury and lifelong impairment in this exceedingly vulnerable patient population.
Conclusion
As the first point of contact, physicians and other health care providers are in a position to fulfill a crucial role in the primary prevention of brain injury in infants, including fetal alcohol syndrome, neonatal abstinence syndome, Zika virus and chorioamnionitis. Steps must be taken to improve awareness about the incidence of preterm births, alcohol use, prescription prescription opioid abuse and infections during pregnancy within the medical community and the public. For Zika virus, prenatal alcohol and opioid exposure, a critical issue is ensuring that pediatric clinicians are aware of maternal exposure, and thus identify infants who should be tested and provided appropriate followup for neurodevelopmental issues (49). Similarly, it is important that public health measures be increased to educate the public about the effects of toxins and illness before and during pregnancy. Safe and judicious prescribing of opioids are Copyright 2017 KEI Journals. All Rights Reserved. encouraged in women of childbearing age, as is recording a thorough and accurate medical history including international travel, recreational drug use such as marijuana and methamphetamine in addition to opioid and alcohol use, and history of medications including selective serotonin reuptake inhibitors and benzodiazepines. While the focus was on opioids and alcohol within the present review, polysubstance use and abuse in pregnant women and the subsequent effect on the fetus cannot be overlooked (297) (298) (299) (300) (301) (302) (303) . Marijuana use is one of the most commonly used drugs in pregnancy and lactation. This is of great concern given the lipophilic nature of cannabis and its metabolites thus allowing for rapid transfer through the maternal-placental fetal axis. Numerous reports of cannabis exposure during critical periods of prenatal development detail increased risks for structural and functional brain injury, including neuropsychiatric, behavioral, and executive function impairment later in life (297, 298, 300-302).
Minimizing brain injury in infants hinges on identification of critical pathways underlying the developmental program shared by both the placenta and brain. This information is essential for understanding the fundamental mechanisms of transmission of inflammatory signaling through the placenta and blood-brain barrier and subsequent impact on neural development. Disruptions in placental function directly affect organ maturation, and the CNS is particularly vulnerable because of its protracted development throughout gestation and postnatally. Individual and specific windows of vulnerability are defined by the gestational age in which infectious agents or toxins are most likely to be transmitted to the fetus and have detrimental consequences (5). This conferred vulnerability varies for different agents, and is based on both pathogen and host factors, including a complex interplay between the cellular, molecular and anatomic factors through the maternal-placental-fetal axis, which evolves with gestation (5). Cumulatively, infections and toxins during fetal development have persistent and chronic impact beyond neurogenesis and neural cell development through inflammation.
Limited avenues for early detection and diagnosis are additional challenges facing Zika virus, prenatal alcohol and opioid exposure, and preterm infant patient populations. However, the placenta may be key to early diagnosis, and stratification for emerging therapies, with the establishment of pathophysiology specific biomarkers linked to brain injury. Even if novel therapies are discovered to treat CNS injury and improve neurological outcome, definitive medical diagnoses are difficult early in life, thus reducing timely and appropriate medical and supportive care. Clinicians often rely on the appearance of neurological deficits and delayed developmental milestones as the infant matures to diagnose neurodevelopmental insults, which limits the use of effective interventions prior to irreversible CNS injury in the neonatal period. Indeed, early indicators of adverse events are needed to contribute to the ontogeny of impairment as it unfolds across the development, and more sensitive detection measures and earlier recognition of phenotypes by pediatric and primary care physicians will help ensure appropriate and timely evaluation and follow-up of affected infants. Undoubtedly, more complete, comprehensive, and multi-specialty clinical assessment of infants will be needed to fully describe the extent of the brain abnormalities and other adverse outcomes in affected fetuses and infants exposed to alcohol, opioids, viruses and/or bacterial infections. Unquestionably, clinical care that is multidisciplinary, collaborative, compassionate and based on the identified needs of the mother-infant dyad will directly benefit all patients with toxin or infectious agent exposure, 
